Category Medical Devices

NextPoint

NextPoint Therapeutics Announces Clinical Debut of Novel NPX372 for Solid Tumor Treatment

NextPoint Therapeutics Announces Clinical Entry of NPX372, a First-in-Class B7-H7–Targeted T Cell Engager to Treat Solid Tumors NextPoint Therapeutics, a clinical-stage biotechnology company developing a new world of precision therapeutics through its…

Read MoreNextPoint Therapeutics Announces Clinical Debut of Novel NPX372 for Solid Tumor Treatment
iNTApharma™

Bruker Introduces iNTApharma™ Platform to Streamline Nanoparticle Characterization and QC

Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC Bruker Corporation today announced the launch of iNTApharma, a label‑free characterization platform that provides single‑particle sensitivity…

Read MoreBruker Introduces iNTApharma™ Platform to Streamline Nanoparticle Characterization and QC